Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy

Tarun Podder; Tithi Biswas; Min Yao; Yuxia Zhang; Ellen Kim; Rodney J. Ellis; Simon S. Lo; Mitchell Machtay

doi:10.2217/fon.14.158

Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy

Tarun Podder, Tithi Biswas, Min Yao, Yuxia Zhang, Ellen Kim, Rodney J. Ellis, Simon S. Lo, Mitchell Machtay

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Abstract

Aim: The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.

Materials & methods: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm³ of chest wall and 1-10 cm³ of ribs.

Results: Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm³ of chest wall and 50.4 Gy to 1 cm³ of rib. Nine patients had more than 30 Gy dose to 30 cm³ of chest wall. No rib bone fracture was found.

Conclusion: No correlations of chest wall pain and volume of irradiation were found.

Original language	English (US)
Pages (from-to)	2311-2317
Number of pages	7
Journal	Future Oncology
Volume	10
Issue number	15
DOIs	https://doi.org/10.2217/fon.14.158
State	Published - Dec 1 2014

All Science Journal Classification (ASJC) codes

Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.2217/fon.14.158

Cite this

@article{c428e0ab4e2848b7bb70a4a2c14dd8fe,

title = "Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy",

abstract = "Aim: The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.Materials & methods: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm3 of chest wall and 1-10 cm3 of ribs.Results: Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm3 of chest wall and 50.4 Gy to 1 cm3 of rib. Nine patients had more than 30 Gy dose to 30 cm3 of chest wall. No rib bone fracture was found.Conclusion: No correlations of chest wall pain and volume of irradiation were found.",

author = "Tarun Podder and Tithi Biswas and Min Yao and Yuxia Zhang and Ellen Kim and Ellis, {Rodney J.} and Lo, {Simon S.} and Mitchell Machtay",

note = "Publisher Copyright: {\textcopyright} 2014 Future Medicine Ltd.",

year = "2014",

month = dec,

day = "1",

doi = "10.2217/fon.14.158",

language = "English (US)",

volume = "10",

pages = "2311--2317",

journal = "Future Oncology",

issn = "1479-6694",

publisher = "Taylor and Francis Ltd.",

number = "15",

}

TY - JOUR

T1 - Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy

AU - Podder, Tarun

AU - Biswas, Tithi

AU - Yao, Min

AU - Zhang, Yuxia

AU - Kim, Ellen

AU - Ellis, Rodney J.

AU - Lo, Simon S.

AU - Machtay, Mitchell

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Aim: The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.Materials & methods: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm3 of chest wall and 1-10 cm3 of ribs.Results: Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm3 of chest wall and 50.4 Gy to 1 cm3 of rib. Nine patients had more than 30 Gy dose to 30 cm3 of chest wall. No rib bone fracture was found.Conclusion: No correlations of chest wall pain and volume of irradiation were found.

AB - Aim: The aim of the study is to evaluate the chest wall and rib toxicities in primary lung cancer patients treated with CyberKnife-based stereotactic body radiotherapy.Materials & methods: In this study, data were collected from the 118 patients, of which 25 patients who had longer follow-up (mean: 21.9 months) were considered. Studied parameters were maximum point dose, doses to 1-100 cm3 of chest wall and 1-10 cm3 of ribs.Results: Three patients developed chest wall pain (grade I). 25 studied patients, on average, received 27.7 Gy to 30 cm3 of chest wall and 50.4 Gy to 1 cm3 of rib. Nine patients had more than 30 Gy dose to 30 cm3 of chest wall. No rib bone fracture was found.Conclusion: No correlations of chest wall pain and volume of irradiation were found.

UR - http://www.scopus.com/inward/record.url?scp=84919965716&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84919965716&partnerID=8YFLogxK

U2 - 10.2217/fon.14.158

DO - 10.2217/fon.14.158

M3 - Article

C2 - 25525841

AN - SCOPUS:84919965716

SN - 1479-6694

VL - 10

SP - 2311

EP - 2317

JO - Future Oncology

JF - Future Oncology

IS - 15

ER -

Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy

Abstract

All Science Journal Classification (ASJC) codes

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this